Related Experiment Video
Updated: Jul 8, 2025

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
ROS-generating nanoplatforms as selective and tunable therapeutic weapons against cancer
Federica Foglietta1, Loredana Serpe2, Roberto Canaparo1
1Department of Drug Science and Technology, University of Torino, Via Pietro Giuria 13, 10125, Turin, Italy.
Abstract:
Reactive species refers to a group of chemicals, mainly reactive oxygen species (ROS) and reactive nitrogen species (RNS), that are naturally formed by cells as a byproduct of cell metabolism and regulated by various internal and external factors. Due to their highly chemical reactivity, ROS play a crucial role in physiological and pathological processes which is why studies on ROS regulation for disease treatment show attracted increasing interest. Notably, ROS are now studied as a powerful therapeutic weapon in ROS-regulating therapies such as ROS-based cytotoxic therapies mediated by ROS-increasing agents for cancer treatment. Thanks to the significant progress in nanotechnology, innovative nanoplatforms with ROS-regulating activities have been developed to look for effective ROS-related nanomedicines. In this review, studies on ROS-based cytotoxic therapies against cancer as photodynamic therapy (PDT), sonodynamic therapy (SDT), radiation therapy (RT) and chemodynamic therapy (CDT) are discussed, with a focus on the stimuli-responsive ROS-generating nanoplatforms developed for breaking the current therapeutic limits of ROS-based cytotoxic therapies. Finally, we suppose that our review on this developing field will be valuable for promoting the progress of ROS-based cytotoxic therapies not only in basic research but overall, in translational research and clinical application.
More Related Videos
07:54Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014